| Pharmaceutical Information |
| Drug Name |
Amlexanox |
| Drug ID |
BADD_D00120 |
| Description |
Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population. |
| Indications and Usage |
Used as a paste in the mouth to treat aphthous ulcers (canker sores). |
| Marketing Status |
Discontinued |
| ATC Code |
A01AD07; R03DX01 |
| DrugBank ID |
DB01025
|
| KEGG ID |
D01828
|
| MeSH ID |
C045742
|
| PubChem ID |
2161
|
| TTD Drug ID |
D0G5UB
|
| NDC Product Code |
71052-005; 73309-350; 72969-097 |
| Synonyms |
amlexanox | 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid | amoxanox | Aphthasol | CHX 3673 | AA 673 | AA-673 |
|
| Chemical Information |
| Molecular Formula |
C16H14N2O4 |
| CAS Registry Number |
68302-57-8 |
| SMILES |
CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
